Raymond James & Associates’s Reviva Pharmaceuticals RVPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,000	Closed	-$52K	–	3883
2022 Q3	$52K	Buy	33,000 +13,000	+65%	+$20.5K	﹤0.01%	3656
2022 Q2	$22K	Buy	20,000 +6,000	+43%	+$6.6K	﹤0.01%	3781
2022 Q1	$34K	Buy	+14,000	New	+$34K	﹤0.01%	3857